UniProt P49720
Proteasome subunit beta type-3 (P49720)
Proteasome subunit beta type-3 (UniProt P49720), EC 3.4.25.1: 61 experimental structures on GenesisL1, 9 ligands bound, 18 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P49720
- Protein
- Proteasome subunit beta type-3
- EC
- 3.4.25.1
- Experimental structures
- 61
- Predicted models
- 0
- Ligands
- 9
- Pockets
- 18 · 6 records with a druggable one
Structures
61 records of P49720 in the MolNFT archive: 61 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 4R3O | Human Constitutive 20S Proteasome | x-ray diffraction | J, X | — | — |
| 4R3O | Human constitutive 20S proteasome | x-ray diffraction | J, X | — | — |
| 4R67 | Human constitutive 20S proteasome in complex with carfilzomib | x-ray diffraction | J, X, l, z | — | — |
| 4R67 | Human constitutive 20S proteasome in complex with carfilzomib | x-ray diffraction | J, X, l, z | — | — |
| 5A0Q | Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core | electron microscopy | J, X | — | — |
| 5GJQ | Structure of the human 26S proteasome bound to USP14-ubal | electron microscopy | c, q | — | — |
| 5GJR | An atomic structure of the human 26S proteasome | electron microscopy | c, q | — | — |
| 5L4G | The human 26S proteasome at 3.9 A | electron microscopy | W, 3 | — | — |
| 5LE5 | Native human 20S proteasome at 1.8 Angstrom | x-ray diffraction | I, W | MG, CL | — |
| 5LE5 | Native human 20S proteasome at 1.8 ångström | x-ray diffraction | I, W | MG, CL | — |
| 5LEX | Native human 20S proteasome in Mg-Acetate at 2.2 Angstrom | x-ray diffraction | I, W | MG | — |
| 5LEX | Native human 20S proteasome in mg-acetate at 2.2 ångström | x-ray diffraction | I, W | MG | — |
| 5LEY | Human 20S proteasome complex with oprozomib at 1.9 ångström | x-ray diffraction | I, W | MG, CL | — |
| 5LEZ | Human 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstrom | x-ray diffraction | I, W | MG | — |
| 5LEZ | Human 20S proteasome complex with oprozomib in mg-acetate at 2.2 ångström | x-ray diffraction | I, W | MG | — |
| 5LF0 | Human 20S proteasome complex with epoxomicin at 2.4 ångström | x-ray diffraction | I, W | ACE, CL, MG | — |
| 5LF1 | Human 20S proteasome complex with dihydroeponemycin at 2.0 ångström | x-ray diffraction | I, W | 6VC, MG, CL | — |
| 5LF3 | Human 20S proteasome complex with bortezomib at 2.1 ångström | x-ray diffraction | I, W | CL, BO2, MG | — |
| 5LF4 | Human 20S proteasome complex with Delanzomib at 2.0 Angstrom | x-ray diffraction | I, W | MG, CL | — |
| 5LF4 | Human 20S proteasome complex with delanzomib at 2.0 ångström | x-ray diffraction | I, W | MG, CL | — |
| 5LF6 | Human 20S proteasome complex with Z-lly-ketoaldehyde at 2.1 ångström | x-ray diffraction | I, W | MG, CL | — |
| 5LF7 | Human 20S proteasome complex with Ixazomib at 2.0 Angstrom | x-ray diffraction | I, W | 6V8, MG, CL | — |
| 5LF7 | Human 20S proteasome complex with ixazomib at 2.0 ångström | x-ray diffraction | I, W | 6V8, MG, CL | — |
| 5LN3 | The human 26S proteasome at 6.8 ang. | electron microscopy | 3 | — | — |
| 5M32 | Human 26S proteasome in complex with oprozomib | electron microscopy | I, W | — | — |
| 5T0G | Structural basis for dynamic regulation of the human 26S proteasome | electron microscopy | P | — | — |
| 5T0G | Structural basis for dynamic regulation of the human 26S proteasome | electron microscopy | P | — | — |
| 5T0H | Structural basis for dynamic regulation of the human 26S proteasome | electron microscopy | P | — | — |
| 5T0I | Structural basis for dynamic regulation of the human 26S proteasome | electron microscopy | P | — | — |
| 5T0J | Structural basis for dynamic regulation of the human 26S proteasome | electron microscopy | P | — | — |
| 5VFO | Nucleotide-driven triple-state remodeling of the aaa-ATPase channel in the activated human 26S… | electron microscopy | P, p | — | — |
| 5VFR | Nucleotide-driven triple-state remodeling of the aaa-ATPase channel in the activated human 26S… | electron microscopy | P, p | — | — |
| 5VFT | Nucleotide-driven triple-state remodeling of the aaa-ATPase channel in the activated human 26S… | electron microscopy | P, p | — | — |
| 5VFU | Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S… | electron microscopy | P, p | — | — |
| 6AVO | Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively… | electron microscopy | U, Y | — | — |
| 6E5B | Human Immunoproteasome 20S particle in complex with compound 1 | x-ray diffraction | I, W | NA | — |
| 6E5B | Human immunoproteasome 20S particle in complex with compound 1 | x-ray diffraction | I, W | NA | — |
| 6KWY | Human PA200-20S complex | electron microscopy | I, W | — | — |
| 6MSD | Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome | electron microscopy | P, p | — | 1 (best 0.79) |
| 6R70 | Endogeneous native human 20S proteasome | electron microscopy | I, W | — | — |
| 6REY | Human 20S-PA200 proteasome complex | electron microscopy | J, X | — | — |
| 6RGQ | Human 20S proteasome | electron microscopy | J, X | — | — |
| 6WJN | Sd-like state of human 26S proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin… | electron microscopy | P, p | — | — |
| 6XMJ | Human 20S proteasome bound to an engineered 11S (PA26) activator | electron microscopy | J | — | — |
| 7AWE | Human immunoproteasome 20S particle in complex with [(1R)-2-(1… | x-ray diffraction | J, X | NA | — |
| 7B12 | HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH… | x-ray diffraction | J, X | NA, SKN | — |
| 7B12 | Human immunoproteasome 20S particle in complex with [2-(3… | x-ray diffraction | J, X | NA, SKN | — |
| 7LXV | Structure of human 20S proteasome with bound mpi-5 | electron microscopy | I, W | — | — |
| 7NHT | Akirin2 bound human proteasome | electron microscopy | I | — | — |
| 7NHT | AKIRIN2 bound human proteasome | electron microscopy | I | — | — |
| 7PG9 | Human 20S proteasome | electron microscopy | J, X | — | — |
| 7V5G | 20S+monoUb-CyclinB1-NT (S1) | electron microscopy | C, J | — | 4 (best 0.79) |
| 7V5G | 20S+MONOUB-CYCLINB1-nt (S1) | electron microscopy | C, J | — | — |
| 7V5M | 20S+monoUb-CyclinB1-NT (S2) | electron microscopy | J, X | — | — |
| 7V5M | 20S+MONOUB-CYCLINB1-nt (S2) | electron microscopy | J, X | — | — |
| 7W39 | Structure of USP14-bound human 26S proteasome in state EA2.1_UBL | electron microscopy | P, p | — | 1 (best 0.79) |
| 7W3I | Structure of USP14-bound human 26S proteasome in substrate-inhibited state SB_USP14 | electron microscopy | P, p | — | — |
| 8CVR | Human 20S proteasome with MG-132 | electron microscopy | J, X | LDZ | 7 (best 0.79) |
| 8QZ9 | Human 20S proteasome assembly intermediate structure 4 | electron microscopy | L | — | 4 (best 0.86) |
| 9E8Q | Nub1/Fat10-processing human 26S proteasome with Rpt2 at top of spiral staircase | electron microscopy | P | — | 1 (best 0.77) |
1 record more on the page itself.
Ligands
- MG · Magnesium ion · in 15 records
- CL · Chloride ion · in 11 records
- NA · Sodium ion · in 5 records
- 6V8 · [(1~{R})-1-[2-[[2,5-bis(chloranyl) phenyl]carbonylamino]ethanoylamino]-3-methyl-butyl]boronic acid · in 2 records
- SKN · ((R)-2-(3-ethylphenyl)-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)ethyl)boronic acid · in 2 records
- 6VC · ~{N}-[(2~{S})-1-[[(2~{S},3~{R},4~{S})-2,6-dimethyl-1,2, 3-tris(oxidanyl)heptan-4-yl]amino]-3-oxidanyl-1-oxidanylidene-propan-2-yl]-6-methyl-heptanamide · in 1 record
- ACE · Acetyl group · in 1 record
- BO2 · N-[(1R)-1-(dihydroxyboryl)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide · in 1 record
- LDZ · N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-4-methyl-1-oxopentan-2-yl]-L-leucinamide · in 1 record
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.